Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway

Objective. The present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts and the mechanisms involved. Methods. A total of 30 diabetic rats induced by high-glucose-fat diet and streptozotocin (STZ) were randomly assi...

Full description

Saved in:
Bibliographic Details
Published inJournal of Diabetes Research Vol. 2018; no. 2018; pp. 1 - 10
Main Authors Li, Zhenghong, Li, Xiaohong, Ye, Hongwei, Wang, Ya, Hu, Jing, Cheng, Xiangyang, Gao, Qin
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Publishing Corporation 01.01.2018
Hindawi
John Wiley & Sons, Inc
Hindawi Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective. The present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts and the mechanisms involved. Methods. A total of 30 diabetic rats induced by high-glucose-fat diet and streptozotocin (STZ) were randomly assigned to five groups: diabetic sham-operated group (DM-S), diabetic I/R group (DM-I/R), diabetic DEX group (DM-D), diabetic DEX + Wort group (DM-DW), and diabetic Wort group (DM-W). Another 12 age-matched male normal SD rats were randomly divided into two groups: sham-operated group (S) and I/R group (I/R). All rats were subjected to 30 min myocardial ischemia followed by 120 min reperfusion except sham groups. Plasmas were collected to measure the malondialdehyde (MDA), creatine kinase isoenzymes (CK-MB), and lactate dehydrogenase (LDH) levels and superoxide dismutase (SOD) activity at the end of reperfusion. Pathologic changes in myocardial tissues were observed by H-E staining. The total and phosphorylated form of Akt and GSK-3β protein expressions were measured by western blot. The ratio of Bcl-2/Bax at mRNA level was detected by reverse transcription-polymerase chain reaction (RT-PCR). Results. DEX significantly reduced plasma CK-MB, MDA concentration, and LDH level and increased SOD activity caused by I/R. The phosphorylation of Akt and GSK-3β was increased, Bcl-2 mRNA and the Bcl-2/Bax ratio was increased, and Bax mRNA was decreased in the DEX group as compared to the I/R group, while posttreatment with Wort attenuated the effects induced by DEX. Conclusion. The results of this study suggest that DEX postconditioning may increase the phosphorylation of GSK-3β by activating the PI3K/Akt signaling pathway and may inhibit apoptosis and oxidative stress of the myocardium, thus exerting protective effects in diabetic rat hearts suffering from I/R injury.
AbstractList Objective . The present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts and the mechanisms involved. Methods . A total of 30 diabetic rats induced by high-glucose-fat diet and streptozotocin (STZ) were randomly assigned to five groups: diabetic sham-operated group (DM-S), diabetic I/R group (DM-I/R), diabetic DEX group (DM-D), diabetic DEX + Wort group (DM-DW), and diabetic Wort group (DM-W). Another 12 age-matched male normal SD rats were randomly divided into two groups: sham-operated group (S) and I/R group (I/R). All rats were subjected to 30 min myocardial ischemia followed by 120 min reperfusion except sham groups. Plasmas were collected to measure the malondialdehyde (MDA), creatine kinase isoenzymes (CK-MB), and lactate dehydrogenase (LDH) levels and superoxide dismutase (SOD) activity at the end of reperfusion. Pathologic changes in myocardial tissues were observed by H-E staining. The total and phosphorylated form of Akt and GSK-3 β protein expressions were measured by western blot. The ratio of Bcl-2/Bax at mRNA level was detected by reverse transcription-polymerase chain reaction (RT-PCR). Results . DEX significantly reduced plasma CK-MB, MDA concentration, and LDH level and increased SOD activity caused by I/R. The phosphorylation of Akt and GSK-3 β was increased, Bcl-2 mRNA and the Bcl-2/Bax ratio was increased, and Bax mRNA was decreased in the DEX group as compared to the I/R group, while posttreatment with Wort attenuated the effects induced by DEX. Conclusion . The results of this study suggest that DEX postconditioning may increase the phosphorylation of GSK-3 β by activating the PI3K/Akt signaling pathway and may inhibit apoptosis and oxidative stress of the myocardium, thus exerting protective effects in diabetic rat hearts suffering from I/R injury.
Objective. The present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts and the mechanisms involved. Methods. A total of 30 diabetic rats induced by high-glucose--fat diet and streptozotocin (STZ) were randomly assigned to five groups: diabetic sham-operated group (DM-S), diabetic I/R group (DM-I/R), diabetic DEX group (DM-D), diabetic DEX + Wort group (DM-DW), and diabetic Wort group (DM-W). Another 12 age-matched male normal SD rats were randomly divided into two groups: sham-operated group (S) and I/R group (I/R). All rats were subjected to 30 min myocardial ischemia followed by 120 min reperfusion except sham groups. Plasmas were collected to measure the malondialdehyde (MDA), creatine kinase isoenzymes (CK-MB), and lactate dehydrogenase (LDH) levels and superoxide dismutase (SOD) activity at the end of reperfusion. Pathologic changes in myocardial tissues were observed by H-E staining. The total and phosphorylated form of Akt and GSK-3[beta] protein expressions were measured by western blot. The ratio of Bcl-2/Bax at mRNA level was detected by reverse transcription-polymerase chain reaction (RT-PCR). Results. DEX significantly reduced plasma CK-MB, MDA concentration, and LDH level and increased SOD activity caused by I/R. The phosphorylation of Akt and GSK-3[beta] was increased, Bcl-2 mRNA and the Bcl-2/Bax ratio was increased, and Bax mRNA was decreased in the DEX group as compared to the I/R group, while posttreatment with Wort attenuated the effects induced by DEX. Conclusion. The results of this study suggest that DEX postconditioning may increase the phosphorylation of GSK-3[beta] by activating the PI3K/Akt signaling pathway and may inhibit apoptosis and oxidative stress of the myocardium, thus exerting protective effects in diabetic rat hearts suffering from I/R injury.
Objective. The present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts and the mechanisms involved. Methods. A total of 30 diabetic rats induced by high-glucose-fat diet and streptozotocin (STZ) were randomly assigned to five groups: diabetic sham-operated group (DM-S), diabetic I/R group (DM-I/R), diabetic DEX group (DM-D), diabetic DEX + Wort group (DM-DW), and diabetic Wort group (DM-W). Another 12 age-matched male normal SD rats were randomly divided into two groups: sham-operated group (S) and I/R group (I/R). All rats were subjected to 30 min myocardial ischemia followed by 120 min reperfusion except sham groups. Plasmas were collected to measure the malondialdehyde (MDA), creatine kinase isoenzymes (CK-MB), and lactate dehydrogenase (LDH) levels and superoxide dismutase (SOD) activity at the end of reperfusion. Pathologic changes in myocardial tissues were observed by H-E staining. The total and phosphorylated form of Akt and GSK-3β protein expressions were measured by western blot. The ratio of Bcl-2/Bax at mRNA level was detected by reverse transcription-polymerase chain reaction (RT-PCR). Results. DEX significantly reduced plasma CK-MB, MDA concentration, and LDH level and increased SOD activity caused by I/R. The phosphorylation of Akt and GSK-3β was increased, Bcl-2 mRNA and the Bcl-2/Bax ratio was increased, and Bax mRNA was decreased in the DEX group as compared to the I/R group, while posttreatment with Wort attenuated the effects induced by DEX. Conclusion. The results of this study suggest that DEX postconditioning may increase the phosphorylation of GSK-3β by activating the PI3K/Akt signaling pathway and may inhibit apoptosis and oxidative stress of the myocardium, thus exerting protective effects in diabetic rat hearts suffering from I/R injury.
The present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts and the mechanisms involved.OBJECTIVEThe present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts and the mechanisms involved.A total of 30 diabetic rats induced by high-glucose-fat diet and streptozotocin (STZ) were randomly assigned to five groups: diabetic sham-operated group (DM-S), diabetic I/R group (DM-I/R), diabetic DEX group (DM-D), diabetic DEX + Wort group (DM-DW), and diabetic Wort group (DM-W). Another 12 age-matched male normal SD rats were randomly divided into two groups: sham-operated group (S) and I/R group (I/R). All rats were subjected to 30 min myocardial ischemia followed by 120 min reperfusion except sham groups. Plasmas were collected to measure the malondialdehyde (MDA), creatine kinase isoenzymes (CK-MB), and lactate dehydrogenase (LDH) levels and superoxide dismutase (SOD) activity at the end of reperfusion. Pathologic changes in myocardial tissues were observed by H-E staining. The total and phosphorylated form of Akt and GSK-3β protein expressions were measured by western blot. The ratio of Bcl-2/Bax at mRNA level was detected by reverse transcription-polymerase chain reaction (RT-PCR).METHODSA total of 30 diabetic rats induced by high-glucose-fat diet and streptozotocin (STZ) were randomly assigned to five groups: diabetic sham-operated group (DM-S), diabetic I/R group (DM-I/R), diabetic DEX group (DM-D), diabetic DEX + Wort group (DM-DW), and diabetic Wort group (DM-W). Another 12 age-matched male normal SD rats were randomly divided into two groups: sham-operated group (S) and I/R group (I/R). All rats were subjected to 30 min myocardial ischemia followed by 120 min reperfusion except sham groups. Plasmas were collected to measure the malondialdehyde (MDA), creatine kinase isoenzymes (CK-MB), and lactate dehydrogenase (LDH) levels and superoxide dismutase (SOD) activity at the end of reperfusion. Pathologic changes in myocardial tissues were observed by H-E staining. The total and phosphorylated form of Akt and GSK-3β protein expressions were measured by western blot. The ratio of Bcl-2/Bax at mRNA level was detected by reverse transcription-polymerase chain reaction (RT-PCR).DEX significantly reduced plasma CK-MB, MDA concentration, and LDH level and increased SOD activity caused by I/R. The phosphorylation of Akt and GSK-3β was increased, Bcl-2 mRNA and the Bcl-2/Bax ratio was increased, and Bax mRNA was decreased in the DEX group as compared to the I/R group, while posttreatment with Wort attenuated the effects induced by DEX.RESULTSDEX significantly reduced plasma CK-MB, MDA concentration, and LDH level and increased SOD activity caused by I/R. The phosphorylation of Akt and GSK-3β was increased, Bcl-2 mRNA and the Bcl-2/Bax ratio was increased, and Bax mRNA was decreased in the DEX group as compared to the I/R group, while posttreatment with Wort attenuated the effects induced by DEX.The results of this study suggest that DEX postconditioning may increase the phosphorylation of GSK-3β by activating the PI3K/Akt signaling pathway and may inhibit apoptosis and oxidative stress of the myocardium, thus exerting protective effects in diabetic rat hearts suffering from I/R injury.CONCLUSIONThe results of this study suggest that DEX postconditioning may increase the phosphorylation of GSK-3β by activating the PI3K/Akt signaling pathway and may inhibit apoptosis and oxidative stress of the myocardium, thus exerting protective effects in diabetic rat hearts suffering from I/R injury.
The present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts and the mechanisms involved. A total of 30 diabetic rats induced by high-glucose-fat diet and streptozotocin (STZ) were randomly assigned to five groups: diabetic sham-operated group (DM-S), diabetic I/R group (DM-I/R), diabetic DEX group (DM-D), diabetic DEX + Wort group (DM-DW), and diabetic Wort group (DM-W). Another 12 age-matched male normal SD rats were randomly divided into two groups: sham-operated group (S) and I/R group (I/R). All rats were subjected to 30 min myocardial ischemia followed by 120 min reperfusion except sham groups. Plasmas were collected to measure the malondialdehyde (MDA), creatine kinase isoenzymes (CK-MB), and lactate dehydrogenase (LDH) levels and superoxide dismutase (SOD) activity at the end of reperfusion. Pathologic changes in myocardial tissues were observed by H-E staining. The total and phosphorylated form of Akt and GSK-3 protein expressions were measured by western blot. The ratio of Bcl-2/Bax at mRNA level was detected by reverse transcription-polymerase chain reaction (RT-PCR). DEX significantly reduced plasma CK-MB, MDA concentration, and LDH level and increased SOD activity caused by I/R. The phosphorylation of Akt and GSK-3 was increased, Bcl-2 mRNA and the Bcl-2/Bax ratio was increased, and Bax mRNA was decreased in the DEX group as compared to the I/R group, while posttreatment with Wort attenuated the effects induced by DEX. The results of this study suggest that DEX postconditioning may increase the phosphorylation of GSK-3 by activating the PI3K/Akt signaling pathway and may inhibit apoptosis and oxidative stress of the myocardium, thus exerting protective effects in diabetic rat hearts suffering from I/R injury.
Audience Academic
Author Li, Zhenghong
Li, Xiaohong
Hu, Jing
Ye, Hongwei
Cheng, Xiangyang
Wang, Ya
Gao, Qin
AuthorAffiliation 1 Department of Anesthesiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China
2 Department of Physiology, Bengbu Medical College, Bengbu, Anhui 233030, China
AuthorAffiliation_xml – name: 1 Department of Anesthesiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China
– name: 2 Department of Physiology, Bengbu Medical College, Bengbu, Anhui 233030, China
Author_xml – sequence: 1
  fullname: Li, Zhenghong
– sequence: 2
  fullname: Li, Xiaohong
– sequence: 3
  fullname: Ye, Hongwei
– sequence: 4
  fullname: Wang, Ya
– sequence: 5
  fullname: Hu, Jing
– sequence: 6
  fullname: Cheng, Xiangyang
– sequence: 7
  fullname: Gao, Qin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30402501$$D View this record in MEDLINE/PubMed
BookMark eNqNkkFv0zAUxyM0xMbYjTOyhISQoKsd23G8A1K1DqgYYipwthzHblxSu8QOo9-Ej4tDS1kRB5JDIuf3fk_v5f8wO3Le6Sx7jOA5QpSOc4jKMYYMccrvZSc5RmRUMIqP9u-EHmdnISxhujjmJS0fZMcYEphTiE6yH1fGaBUD8AZM9feVrnX0K1tbp8GND1F5V9tovbNuAbwD7zdeya62sgWzoBq9snI812vdmT4kCszcsu82wDowtbLS0SowlzFcgLlv9dAkNkk8w-_Gky9xNE2VrtYugo924WQ7NLmRsbmVm0fZfSPboM92z9Ps8-urT5dvR9cf3swuJ9cjxSCKoyoNX0qmZVFXnBSKIAoxz41kyFBiCmMqxSSqc4oJUqg2OccI6xKZghkoGT7NZltv7eVSrDu7kt1GeGnFrwPfLYTs0hitFrTIIeOUwlJxQnJT8RxyYgzBWJlkTq5XW9e6r9ImVRqsk-2B9PCLs41Y-G-iQLxgnCfB852g8197HaJY2aB020qnfR9EjjAsISIMJvTpX-jS913aYaIIZAVhw6B7aiHTANYZn_qqQSomtGQFpTgf2p7_g0p3nf5vSoA2Np0fFDy7U9Bo2cYm-LYfghIOwZdbUHU-hE6b_TIQFEOCxZBgsUtwwp_cXeAe_p3XBLzYAo11tby1_6nTidFG_qFRmeIA8U8lAAI1
CitedBy_id crossref_primary_10_17816_phf18527
crossref_primary_10_1053_j_jvca_2023_10_004
crossref_primary_10_1016_j_drudis_2020_01_017
crossref_primary_10_1007_s13577_019_00282_0
crossref_primary_10_1097_SHK_0000000000001637
crossref_primary_10_1002_prp2_700
crossref_primary_10_1016_j_biopha_2024_116764
crossref_primary_10_1248_bpb_b20_00482
crossref_primary_10_3892_mmr_2020_10942
crossref_primary_10_1007_s00101_020_00912_5
crossref_primary_10_3389_fphar_2022_949754
crossref_primary_10_3389_fphar_2022_964475
crossref_primary_10_1007_s00540_023_03261_w
crossref_primary_10_3389_fcell_2021_756483
crossref_primary_10_1002_kjm2_12092
crossref_primary_10_1016_j_biopha_2020_110188
crossref_primary_10_1002_jcb_29318
crossref_primary_10_1007_s00210_019_01755_7
crossref_primary_10_1016_j_ijcard_2021_03_016
crossref_primary_10_1155_2020_6120194
crossref_primary_10_3390_cells11091553
crossref_primary_10_1007_s10557_024_07579_9
crossref_primary_10_1155_2020_6286571
crossref_primary_10_3892_etm_2021_10242
crossref_primary_10_3389_fphar_2019_01641
crossref_primary_10_1213_ANE_0000000000005243
crossref_primary_10_3389_fphar_2022_988254
crossref_primary_10_3389_fncel_2022_899484
crossref_primary_10_1007_s12265_021_10125_9
crossref_primary_10_3390_ijms22052519
crossref_primary_10_1007_s11033_022_07468_0
crossref_primary_10_3390_life11111123
crossref_primary_10_1016_j_jstrokecerebrovasdis_2019_01_016
crossref_primary_10_1536_ihj_19_687
crossref_primary_10_1113_EP088024
crossref_primary_10_1155_2022_5107948
crossref_primary_10_1155_2022_7809485
crossref_primary_10_1002_2211_5463_13276
crossref_primary_10_1016_j_lfs_2020_118628
Cites_doi 10.1016/j.jss.2012.02.021
10.1016/j.ijcard.2013.06.037
10.1016/j.bbi.2017.03.006
10.1016/j.bbrc.2017.08.017
10.1097/SHK.0b013e31825b5633
10.1677/JOE-09-0462
10.1016/j.ejphar.2009.11.032
10.1159/000452598
10.1016/j.ejphar.2015.08.056
10.1111/1440-1681.12791
10.1038/cddis.2014.61
10.1097/SHK.0b013e318254d3fb
10.4103/1673-5374.217337
10.1016/j.ijbiomac.2015.11.045
10.1007/s10557-010-6234-z
10.3892/etm.2017.4457
10.1002/prp2.45
10.2337/db06-0907
10.1016/j.etap.2017.03.017
10.1186/s12967-017-1166-z
10.1016/j.brainres.2012.11.047
10.1016/j.cardiores.2003.09.024
10.3892/mmr.2016.5345
10.1097/CAD.0000000000000500
10.3402/ljm.v10.27828
10.1016/j.yjmcc.2005.07.004
10.3892/mmr.2016.5695
10.1016/j.freeradbiomed.2013.05.043
10.1016/j.cardiores.2006.01.024
10.1046/j.1471-4159.2003.01756.x
10.1186/1475-2840-11-67
10.1111/j.2042-7158.2011.01382.x
10.1016/j.ijcard.2016.01.119
10.1155/2013/653789
10.2337/diabetes.52.2.434
10.1161/CIRCULATIONAHA.115.019790
10.1371/journal.pone.0093639
10.2174/157339911797415585
10.1016/j.coph.2008.11.009
10.1002/path.4113
ContentType Journal Article
Copyright Copyright © 2018 Xiangyang Cheng et al.
COPYRIGHT 2018 John Wiley & Sons, Inc.
Copyright © 2018 Xiangyang Cheng et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2018 Xiangyang Cheng et al. 2018
Copyright_xml – notice: Copyright © 2018 Xiangyang Cheng et al.
– notice: COPYRIGHT 2018 John Wiley & Sons, Inc.
– notice: Copyright © 2018 Xiangyang Cheng et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2018 Xiangyang Cheng et al. 2018
DBID ADJCN
AHFXO
RHU
RHW
RHX
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7RV
7X7
7XB
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
M0T
NAPCQ
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1155/2018/3071959
DatabaseName الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Open Access Journals (Hindawi Publishing)
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Nursing and Allied Health Journals
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
Healthcare Administration Database
Nursing & Allied Health Premium
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Public Health
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Health Management
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef


Publicly Available Content Database
MEDLINE - Academic
MEDLINE



Database_xml – sequence: 1
  dbid: RHX
  name: Open Access Journals (Hindawi Publishing)
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2314-6753
Editor Pernomian, Larissa
Editor_xml – sequence: 1
  givenname: Larissa
  surname: Pernomian
  fullname: Pernomian, Larissa
– fullname: Larissa Pernomian
EndPage 10
ExternalDocumentID oai_doaj_org_article_5620795508c9442fb92094ff433cfdf2
A587655329
10_1155_2018_3071959
30402501
1183410
Genre Journal Article
GeographicLocations United States--US
China
GeographicLocations_xml – name: China
– name: United States--US
GrantInformation_xml – fundername: Anhui Provincial Education Department Project
  grantid: KJ2018A0212
– fundername: Natural Science Foundation of Anhui Province
  grantid: 1508085MH170; 1508085MH169
– fundername: National Natural Science Foundation of China
  grantid: 81770297
– fundername: Bengbu Medical College
  grantid: Byycx1625; BYKF1786
GroupedDBID 24P
4.4
53G
5VS
7RV
7X7
8C1
8FI
8FJ
AAFWJ
AAJEY
AAKDD
ABDBF
ABUWG
ADBBV
ADJCN
ADRAZ
AENEX
AFKRA
AFPKN
AHFXO
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
DIK
EBD
EBS
EJD
EMOBN
ESX
FYUFA
GROUPED_DOAJ
H13
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M0T
M48
NAPCQ
OK1
PGMZT
PIMPY
RHX
RPM
SV3
TUS
UKHRP
~8M
ADMBK
RHU
RHW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
M~E
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c701t-b3078a7ea6db946c4150392fa71f54f6ffbc7a1d25341c1df29313e81f67f0a73
IEDL.DBID RPM
ISSN 2314-6745
2314-6753
IngestDate Mon Oct 07 19:34:02 EDT 2024
Tue Sep 17 21:13:48 EDT 2024
Sat Oct 26 04:12:35 EDT 2024
Thu Oct 10 17:51:15 EDT 2024
Wed Oct 16 18:05:19 EDT 2024
Tue Oct 15 04:48:10 EDT 2024
Tue Oct 15 02:43:34 EDT 2024
Fri Aug 23 03:07:56 EDT 2024
Sat Nov 02 12:29:35 EDT 2024
Sun Jun 02 18:54:59 EDT 2024
Wed Nov 06 05:55:52 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2018
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c701t-b3078a7ea6db946c4150392fa71f54f6ffbc7a1d25341c1df29313e81f67f0a73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Academic Editor: Larissa Pernomian
ORCID 0000-0003-0905-7743
0000-0002-7599-4295
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196799/
PMID 30402501
PQID 2407647931
PQPubID 4727240
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_5620795508c9442fb92094ff433cfdf2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6196799
proquest_miscellaneous_2130801470
proquest_journals_2407647931
gale_infotracmisc_A587655329
gale_infotracacademiconefile_A587655329
gale_healthsolutions_A587655329
crossref_primary_10_1155_2018_3071959
pubmed_primary_30402501
hindawi_primary_10_1155_2018_3071959
emarefa_primary_1183410
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: England
– name: Cairo
PublicationTitle Journal of Diabetes Research
PublicationTitleAlternate J Diabetes Res
PublicationYear 2018
Publisher Hindawi Publishing Corporation
Hindawi
John Wiley & Sons, Inc
Hindawi Limited
Publisher_xml – name: Hindawi Publishing Corporation
– name: Hindawi
– name: John Wiley & Sons, Inc
– name: Hindawi Limited
References 22
24
25
26
27
28
29
(23) 2014; 115
30
31
10
32
11
33
12
34
13
35
14
36
15
37
16
38
17
39
18
19
1
2
3
4
5
6
7
8
9
40
41
20
21
References_xml – ident: 12
  doi: 10.1016/j.jss.2012.02.021
– ident: 13
  doi: 10.1016/j.ijcard.2013.06.037
– ident: 21
  doi: 10.1016/j.bbi.2017.03.006
– ident: 22
  doi: 10.1016/j.bbrc.2017.08.017
– ident: 34
  doi: 10.1097/SHK.0b013e31825b5633
– ident: 37
  doi: 10.1677/JOE-09-0462
– ident: 10
  doi: 10.1016/j.ejphar.2009.11.032
– ident: 17
  doi: 10.1159/000452598
– volume: 115
  start-page: 494
  issue: 8
  year: 2014
  ident: 23
  publication-title: Bratislavské Lekárske Listy
– ident: 26
  doi: 10.1016/j.ejphar.2015.08.056
– ident: 3
  doi: 10.1111/1440-1681.12791
– ident: 35
  doi: 10.1038/cddis.2014.61
– ident: 15
  doi: 10.1097/SHK.0b013e318254d3fb
– ident: 6
  doi: 10.4103/1673-5374.217337
– ident: 18
  doi: 10.1016/j.ijbiomac.2015.11.045
– ident: 33
  doi: 10.1007/s10557-010-6234-z
– ident: 25
  doi: 10.3892/etm.2017.4457
– ident: 19
  doi: 10.1002/prp2.45
– ident: 11
  doi: 10.2337/db06-0907
– ident: 41
  doi: 10.1016/j.etap.2017.03.017
– ident: 8
  doi: 10.1186/s12967-017-1166-z
– ident: 20
  doi: 10.1016/j.brainres.2012.11.047
– ident: 2
  doi: 10.1016/j.cardiores.2003.09.024
– ident: 14
  doi: 10.3892/mmr.2016.5345
– ident: 16
  doi: 10.1097/CAD.0000000000000500
– ident: 24
  doi: 10.3402/ljm.v10.27828
– ident: 30
  doi: 10.1016/j.yjmcc.2005.07.004
– ident: 39
  doi: 10.3892/mmr.2016.5695
– ident: 27
  doi: 10.1016/j.freeradbiomed.2013.05.043
– ident: 7
  doi: 10.1016/j.cardiores.2006.01.024
– ident: 38
  doi: 10.1046/j.1471-4159.2003.01756.x
– ident: 4
  doi: 10.1186/1475-2840-11-67
– ident: 32
  doi: 10.1111/j.2042-7158.2011.01382.x
– ident: 36
  doi: 10.1016/j.ijcard.2016.01.119
– ident: 5
  doi: 10.1155/2013/653789
– ident: 28
  doi: 10.2337/diabetes.52.2.434
– ident: 31
  doi: 10.1161/CIRCULATIONAHA.115.019790
– ident: 40
  doi: 10.1371/journal.pone.0093639
– ident: 29
  doi: 10.2174/157339911797415585
– ident: 9
  doi: 10.1016/j.coph.2008.11.009
– ident: 1
  doi: 10.1002/path.4113
SSID ssj0000939858
ssib050733531
Score 2.3341136
Snippet Objective. The present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts...
The present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts and the...
Objective . The present study was designed to determine whether dexmedetomidine (DEX) exerts cardioprotection against myocardial I/R injury in diabetic hearts...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
hindawi
emarefa
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1
SubjectTerms Animals
Antibodies
Apoptosis
Care and treatment
Complications and side effects
Dexmedetomidine - pharmacology
Diabetes
Diabetes Mellitus, Experimental - metabolism
Glycogen Synthase Kinase 3 beta
Heart
Heart - drug effects
Heart diseases
Hyperglycemia
Insulin resistance
Ischemia
Ischemic Postconditioning - methods
Kinases
Laboratory animals
Male
Medical research
Medicine, Experimental
Myocardial Ischemia - drug therapy
Myocardial Ischemia - metabolism
Myocardial Reperfusion Injury - drug therapy
Myocardial Reperfusion Injury - metabolism
Myocardium - metabolism
Oxidative stress
Phosphatidylinositol 3-Kinases - metabolism
Phosphorylation
Proteins
Proto-Oncogene Proteins c-akt - metabolism
Rats
Rats, Sprague-Dawley
Risk factors
Rodents
Signal Transduction - drug effects
Type 2 diabetes
Veins & arteries
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1db9MwFLXQJBAvaHyNQgEjDfEUNV-2Y94KY1pBRdNg0t4ix7FZYEumNdXYP-Hncpy4pUFIe-Gx9W0d-x7fe65j30vIbigzHpZhGWgshwD8nwcqLsPAWp1xZUutuvop88_84Dj9eMJONkp9uTNhfXrgfuIm8M-hkODRmZZpGttCxohIrE2TRNvS9tY3lBvBFJDEXClC5t9vdTZZJjLrinWCz6QBFylbnYJnbAInmE0AdpdoZeCfujT-3V1dhc9qbbZvn7qA-ar6Fy39-3Tlhrva3yb3PM-k035898ktUz8gd-b-TfpD8qtPW7ygjaV75if-yLTNeQVPZqgr4Iswuaz8Zi1tajq_htNzYDqjMwTE5rxSE5B3c2mXbr-Nzurv0A6tatqfsak0PVLt4i09as6M6wREkx7Okk-T6Y822POld1v6pfrmQgF0cggueqWuH5Hj_Q9f3x8EvkpDoEUYtUGBicuUMIqXhUy5BiMIQbqsEpFlqeXWFlqoqIwZHKaOoDKZRInJIsuFDZVIHpOtuqnNE0JtmRRWyVQwKyErgRMIZYUGzxDGsBF5vdJNftEn48i7IIax3Okw9zockXdOcWsZl0K7-wLAyj2w8puANSI7Xu1_-oL9S6NwRF46GOT9TdW1icinDK6FsSTGA7zpJJyRAAa08ncdMEyXbmsgOR5IYnHrQfOuh9oNAx6vcJh7G7TIXazO3cZpNCKv1s2uA3eurjbNEjKgMC5_kMCgdnrYrjtKYN9BkPFrMQD0YFqHLXV12mUoR1TOhZRP_4cenpG7bqj9tteYbLWXS_McRLAtXnRr_jco1FPw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Open Access Journals (Hindawi Publishing)
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1db9MwFLXYJBAviM9RKGCkIZ6iJk1sx7wVxtSCiqbCpL5FjmOzwJagNdXYP-Hncpy4hQwkeEx9G9u5x_ee649rQvZDmfKwCItAYzgE4P88UOMiDKzVKVe20Kq9P2X-gU-Pk3dLtvRJklZ_LuHD2yE8j9IRoOjSoOyQnTR1428xXW5gw9y9g8wvZrUGWMYybW_mBHlJAi4SttnyfuV1PWfU5uxvD-YqPKutjb5-4qLji_JvHPTqVsrffNPhbXLLk0o66VBwh1wz1V1yY-6Xze-RH12O4hWtLT0w3_Ei09RnJdyWoe62XsTERelnZmld0fklPJxDzimdIfo1Z6Uagambc7t2k2t0Vn2BKmhZ0W5DTanpQjWrV3RRnxpXCVglPZrF70eTr01w4O_ZbejH8rPj_ajkCMTzQl3eJ8eHbz-9mQb-SoZAizBqghwfLlXCKF7kMuEa7j8Ew7JKRJYllluba6GiYszgHXVUWLCJKDZpZLmwoRLxA7Jb1ZV5SKgt4twqmQhmJWQlQAGhNNcgFcIYNiAvNrrJvnWZN7I2YmEsczrMvA4H5LVT3FbG5ctufwCGMj_8MrC8UEhEY6mWSTK2uRwjrrU2iWNt0coB2fNq_1UXjF0ShQPyzMEg646lbu1BNmHwI4zFYzTgZSvhLAIwoJU_2IBuutxaPclhTxIjWfeK9z3U_tHh4QaHmTc4q8wF5tzNkkYD8nxb7Cpwm-gqU68hA77ikgUJdGqvg-22ohjGHGwY_xY9QPc-a7-kKk_adOQIwbmQ8tH_tf4xuekeu1msIdltztfmCXhdkz9tR_VPSjhCKQ
  priority: 102
  providerName: Hindawi Publishing
– databaseName: ProQuest Public Health Database
  dbid: 8C1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdgCMQL4nMUChhpiKeo-bId84LKxrSCiqbBpL1FjmNvgS0Zbaqx_4Q_lzvHzQhC8NjmWtu5893vzuc7QrZCmfGwDMtAw3YIAP_zQMVlGFirM65sqZXrnzL_xPcO0w9H7MgH3JY-rXKtE52iLhuNMfIJeh4cw0DR2_PvAXaNwtNV30LjOrkRgZ3DlL5su5dXhg0JmT_lcppZJjJzLTsB1aQBFylb58IzNgFTmE1A5LHcysBKuWL-7saugs-qV943T9Btvqj-Bk7_zLH8zWjt3iV3PNqk00487pFrpr5Pbs39efoD8rMrXrykjaU75gf8kWmbswrsmaHYxhec5bLyIVva1HR-CaYPReqUzsAtNmeVmgCENwu7wqgbndVfgUe0qmmXaVNpeqDa5Rt60JwaHATgJt2fJR8n029tsOMb8Lb0c3WMDgEMsg-I9EJdPiSHu--_bO8FvldDoEUYtUEBLy5TwiheFjLlGnBBCNDLKhFZllpubaGFisqYgdnUUWkBZkSJySLLhQ2VSB6RjbqpzWNCbZkUVslUMCuBVoK0AFFWaEAbwhg2Iq_WvMnPu5IcuXNlGMuRh7nn4Yi8Q8b1NFhI233RLI5zvy9zgH-hkOCmZVqmaWwLGYPDa22aJNrCLEdk07P9aizQgmkUjsgLFIO8u6_aK4p8ysDAMJbEMIHXjgJVBciAVv7GAywTi24NKMcDStjievB4y4vafxY8Xsth7jXRMr_aNyPysn-MA2B2XW2aFdAAkMEqQgIWtdmJbT9QAloeYDL8WgwEevBah0_q6sTVKQffnAspn_x7Wk_JbVxEF9Yak412sTLPAOi1xXO3m38Bt2NMIg
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1tb9MwELbGENO-IF63QAEjDfEpNG-OYySECmNaQUXToNK-RY5jb4EugTbV1n_Cz-UucQqZhvjY5hq_3HO-51z7jpA9TySxl3u5q8AcXOD_sSuD3HONUUksTa5kUz9l8jk-nEYfT9jJBumqjdoJXFwb2mE9qel89ury5-otGPybxuAZg_jdT4aAVcyTcoPcDCKI0fEQnyX6zZosQpGwpDv5fuVH22QLonpkA37PPTVZ_JuruhI-y_WqfesM4-WL4jpWevVw5V_e6uAOuW1pJh21uLhLNnR5j2xN7B_p98mvNmvxglaG7utLeJGuq_MCHJmmWL8XouS8sHu1tCrpZAU-D7E0o2OYNH1eyCFwdz03S9xuo-PyGyiHFiVtj9gUih7LevGaHlczjY0Az6RH4_DTcPS9dvdt5d2afilOMRKARo6Ail7I1QMyPfjw9f2ha4s0uIp7fu1mMIeJ5FrGeSaiWAEh8IBzGcl9wyITG5MpLv08YOAvlZ8b4Bd-qBPfxNx4kocPyWZZlXqXUJOHmZEi4swIkBUAExBKMgU0g2vNHPKi0036o83FkTYxDGMpqjO16nTIO1TcWgYzaDdfVPPT1BpkCrzP4wLis0SJKApMJgKIdI0B8CgDvXTIjlX7n7Zg-Yt8zyHPEAZpe1F1vUKkIwaehbEwgA68bCQQtYABJe1VBxgmZtvqSQ56kmDbqvd4z0LtPwMedDhMOwtKMVSPcd_Ud8jz9WNsAI_VlbpaggwwGEwfxGFQOy1s1w11FuEQ3gN0b1r7T8rirElQDkF5zIV49M93Pibb2P92K2tANuv5Uj8BcldnTxu7_Q1Zrkhl
  priority: 102
  providerName: Scholars Portal
Title Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway
URI https://search.emarefa.net/detail/BIM-1183410
https://dx.doi.org/10.1155/2018/3071959
https://www.ncbi.nlm.nih.gov/pubmed/30402501
https://www.proquest.com/docview/2407647931
https://www.proquest.com/docview/2130801470
https://pubmed.ncbi.nlm.nih.gov/PMC6196799
https://doaj.org/article/5620795508c9442fb92094ff433cfdf2
Volume 2018
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2Iaa9ID5HoBQjDfGUJWniOOat6zqtoE5VYVLfIsext0CbTG2qsRf-Dv5czo5bCEJC4sVSm2sd575-55zvEDryWRL7uZ-7AtTBBfwfu7yX-65SIom5ygU3_VPGF_H5ZfRhRmY7iGzOwpikfZEVx-V8cVwW1ya38mYhvE2emDcZDwD0x5QxbxftgoC2Q3SiuxAS-2rLmGMWssT06QQoE7kxjcgmAZ4QiP2DxAM51zVWDtA-BPcaFAQtL2WK-ZsTuxw-863xvn-tw-bb4m_g9M8cy9-c1tlD9MCiTdxvVvUI7cjyMdof2_fpT9CPpnjxClcKn8pv8EeyrhYF-DOJdRtfCJbzwm7Z4qrE4ztwfVqk5ngEYbFcFNwDCC-Xaq133fCo_AI8wkWJm0ybQuApr1fv8bSaSz0JwE08GYUfvf7X2j21DXhr_Km40gEBTDIBRHrL756iy7Ph58G5a3s1uIL6Qe1m8AwTTiWP84xFsQBc4AP0UpwGikQqVioTlAd5j4DbFEGuAGYEoUwCFVPlcxo-Q3tlVcrnCKs8zBRnESWKAS0DaQGiJBOANqiUxEFvN7xJb5qSHKkJZQhJNTtTy04HnWjGbWl0IW3zRbW8Sq04pQD_fMogTEsEi6KeylgPAl6lojAUCu7SQYeW7b_mAisYBb6DXmsxSJvzqltDkfYJOBhCwh7cwDtDoU0FyIDg9sQDLFMX3WpRdlqUoOKidfnIito_FtzZyGFqLdEq1RF7rLdPAwe92V7WE-jsulJWa6ABIKOrCFFY1GEjttuJNhrhINoS6NZjbV8BtTV1yq2avvjvX75EB3p9zY5XB-3Vy7V8BRiwzrqg-TMKYzIIuujeyfBiMu2a_RQYx1Gix-9DGKfns66xDz8B5FZcuw
link.rule.ids 230,315,730,783,787,866,867,880,881,888,2109,2228,12068,12235,21400,24330,27936,27937,31731,31732,33278,33279,33756,33757,43322,43591,43817,53804,53806,74073,74342,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdgiI8XxNe2QmFGGuIpatLEccwLKhtTy9ZpGpu0N8tx7C1sS0abauw_4c_lLnEzghA8trnWdu7rd2f7jpBNXySxn_mZp0EdPMD_saeGme9Zq5NY2Uyrun_KdD8eH0dfTtiJS7jN3bHKpU2sDXVWasyRDzDyiDENFHy8-u5h1yjcXXUtNO6Se-D2BSpmstXKK8OGhMztctWWWYQiqVt2AqqJvJhHbHkWnrEBuMJkACKP5VY6Xqou5l_f2FXwWbXG-_4Zhs3X-d_A6Z9nLH9zWjtPyGOHNumoEY-n5I4pnpEHU7ef_pz8bIoXz2lp6bb5AX9kqvIyB39mKLbxhWA5y13KlpYFnd6A60ORuqATCIvNZa4GAOHNzC4w60YnxTfgEc0L2py0yTU9VNX8Az0sLwwOAnCTHkzC3cHovPK2XQPein7NTzEggEEOAJFeq5sX5Hjn89HW2HO9GjzN_aDyUnhxieJGxVkqolgDLvABelnFA8siG1ubaq6CbMjAbeogswAzgtAkgY259RUPV8lKURZmnVCbhalVIuLMCqAVIC1AlKQa0AY3hvXIuyVv5FVTkkPWoQxjEnkoHQ975BMyrqXBQtr1F-XsVDq9lAD_fC4gTEu0iKKhTcUQAl5rozDUFmbZI2uO7bdjgRWMAr9HNlAMZHNftTUUcsTAwTAWDmEC72sKNBUgA1q5Gw-wTCy61aHsdyhBxXXn8aYTtf8suL-UQ-ks0Vze6k2PvG0f4wB4uq4w5QJoAMhgFSEOi1prxLYdKAQrDzAZfs07At15rd0nRX5W1ymH2DzmQrz897Q2yMPx0XRP7k32d1-RR7igJsXVJyvVbGFeA-ir0je1Zv8Cj3FPFQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdgiIkXxOdWKMxIQzxF-XQc84LKSrUyOlWDSXuLHMfeAlsy2lRj_wl_LneJmxGE4LHNtbZzX7-zz3eE7Hoiib3cyx0F6uAA_o8dGeSeY4xKYmlyJZv-KbPDeP84-njCTmz-09KmVa5tYmOo80rhHrmLkUeM20C-a2xaxHw8eXf53cEOUnjSattp3CZ3wCtG2M0g2etkl2FzQmZPvBorLUKRNO07AeFETswjts6LZ8wFt5i4IP5YeqXnsZrC_s3tXQmfZWfI755hCH1V_A2o_plv-ZsDmzwg9y3ypKNWVB6SW7p8RDZn9mz9MfnZFjJe0srQsf4Bf6Tr6qIA36YptvSFwDkv7PYtrUo6uwY3iOJ1TqcQIuuLQroA5_XCrHAHjk7Lr8AvWpS0zbopFD2S9fItParONQ4C0JPOp-GBO_pWO2PbjLemn4tTDA5gkDmg0yt5_YQcTz582dt3bN8GR3HPr50MXlwiuZZxnokoVoARPIBhRnLfsMjExmSKSz8PGLhQ5ecGIIcf6sQ3MTee5OFTslFWpd4m1ORhZqSIODMCaAVIDhAlmQLkwbVmA_J6zZv0si3PkTZhDWMp8jC1PByQ98i4jgaLajdfVIvT1OpoClDQ4wJCtkSJKApMJgIIfo2JwlAZmOWAbFm234wFFjHyvQHZQTFI27urndFIRwycDWNhABN401Cg2QAZUNLefoBlYgGuHuWwRwnqrnqPd62o_WfBw7UcptYqLdMbHRqQV91jHAAz7UpdrYAGQA1WFOKwqK1WbLuBQrD4AJnh17wn0L3X2n9SFmdNzXKI02MuxLN_T2uHbIJSp5-mhwfPyT1cT7vbNSQb9WKlXwD-q7OXjWL_ArfbU0Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Dexmedetomidine+Postconditioning+on+Myocardial+Ischemia%2FReperfusion+Injury+in+Diabetic+Rats%3A+Role+of+the+PI3K%2FAkt-Dependent+Signaling+Pathway&rft.jtitle=Journal+of+diabetes+research&rft.au=Cheng%2C+Xiangyang&rft.au=Hu%2C+Jing&rft.au=Wang%2C+Ya&rft.au=Ye%2C+Hongwei&rft.date=2018-01-01&rft.eissn=2314-6753&rft.volume=2018&rft.spage=3071959&rft_id=info:doi/10.1155%2F2018%2F3071959&rft_id=info%3Apmid%2F30402501&rft.externalDocID=30402501
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2314-6745&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2314-6745&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2314-6745&client=summon